American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
L Harris, H Fritsche, R Mennel, L Norton… - Journal of clinical …, 2007 - ascopubs.org
Purpose To update the recommendations for the use of tumor marker tests in the prevention,
screening, treatment, and surveillance of breast cancer. Methods For the 2007 update, an …
screening, treatment, and surveillance of breast cancer. Methods For the 2007 update, an …
Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
Profiling breast cancer with expression arrays has become common, and it has been
suggested that the results from early studies will lead to understanding of the molecular …
suggested that the results from early studies will lead to understanding of the molecular …
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
C Ginestier, MH Hur, E Charafe-Jauffret, F Monville… - Cell stem cell, 2007 - cell.com
Application of stem cell biology to breast cancer research has been limited by the lack of
simple methods for identification and isolation of normal and malignant stem cells. Utilizing …
simple methods for identification and isolation of normal and malignant stem cells. Utilizing …
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
BG Haffty, Q Yang, M Reiss, T Kearney… - Journal of clinical …, 2006 - ascopubs.org
Purpose To determine the prognostic significance of triple negative breast cancers with
respect to locoregional relapse and distant metastasis in conservatively managed breast …
respect to locoregional relapse and distant metastasis in conservatively managed breast …
[HTML][HTML] Degradation of proteins by PROTACs and other strategies
Y Wang, X Jiang, F Feng, W Liu, H Sun - Acta Pharmaceutica Sinica B, 2020 - Elsevier
Blocking the biological functions of scaffold proteins and aggregated proteins is a
challenging goal. PROTAC proteolysis-targeting chimaera (PROTAC) technology may be …
challenging goal. PROTAC proteolysis-targeting chimaera (PROTAC) technology may be …
Gene expression profiling of breast cell lines identifies potential new basal markers
A better molecular characterization of breast cell lines (BCL) may help discover new markers
to apply to tumour samples. We performed gene and protein expression profiling of 31 BCL …
to apply to tumour samples. We performed gene and protein expression profiling of 31 BCL …
A new genome‐driven integrated classification of breast cancer and its implications
Breast cancer is a group of heterogeneous diseases that show substantial variation in their
molecular and clinical characteristics. This heterogeneity poses significant challenges not …
molecular and clinical characteristics. This heterogeneity poses significant challenges not …
Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes
MJ Kim, JY Ro, SH Ahn, HH Kim, SB Kim, G Gong - Human pathology, 2006 - Elsevier
DNA microarray profiling studies have led to the classification of invasive breast carcinoma
into luminal/estrogen receptor–positive, normal breast–like, Her2/neu-overexpressing, and …
into luminal/estrogen receptor–positive, normal breast–like, Her2/neu-overexpressing, and …
Integrated profiling of basal and luminal breast cancers
Basal and luminal are two molecular subtypes of breast cancer with opposite histoclinical
features. We report a combined, high-resolution analysis of genome copy number and gene …
features. We report a combined, high-resolution analysis of genome copy number and gene …
GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model
How breast cancers are able to disseminate and metastasize is poorly understood. Using a
hyperplasia transplant system, we show that tumor dissemination and metastasis occur in …
hyperplasia transplant system, we show that tumor dissemination and metastasis occur in …